Epidermal Growth Factor Receptor and K-ras Mutations in Patients With Stage III Non-Small Cell Lung Cancer
CompletedOBSERVATIONAL
Enrollment
60
Participants
Timeline
Start Date
November 30, 2005
Primary Completion Date
March 31, 2006
Study Completion Date
July 31, 2010
Conditions
Lung Cancer
Interventions
GENETIC
molecular diagnostic method
GENETIC
mutation analysis
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Alliance for Clinical Trials in Oncology
OTHER
NCT00898924 - Epidermal Growth Factor Receptor and K-ras Mutations in Patients With Stage III Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter